Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | NPC1 | O15118 | 3/20 | 0.40 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.40 |
| ▸ | CLK1 | P49759 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | PPARD | Q03181 | 1/20 | 0.40 |
| ▸ | AURKA | O14965 | 1/20 | 0.39 |
| ▸ | GSK3A | P49840 | 1/20 | 0.39 |
| ▸ | GSK3B | P49841 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16294585 | 0.87 | PTPN7 (0.45) | MEN1KMT2APTPN7ALDH1A1MAPT | |
| SCHEMBL29420163 | 0.87 | PTPN7 (0.45) | MEN1KMT2APTPN7ALDH1A1MAPT | |
| SCHEMBL29005651 | 0.84 | LMNA (0.46) | MEN1KMT2APTPN7ALDH1A1MAPT | |
| SCHEMBL29897187 | 0.84 | LMNA (0.46) | MEN1KMT2APTPN7ALDH1A1MAPT | |
| SCHEMBL5030826 | 0.82 | NPC1 (0.47) | MEN1KMT2APTPN7ALDH1A1MAPT | |
| SCHEMBL16285732 | 0.82 | MAPT (0.49) | MEN1KMT2APTPN7ALDH1A1MAPT | |
| SCHEMBL5030823 | 0.82 | PTPN7 (0.46) | MEN1KMT2APTPN7ALDH1A1MAPT | |
| SCHEMBL29899356 | 0.82 | PPARD (0.45) | MEN1KMT2APTPN7ALDH1A1MAPT | |
| SCHEMBL3496177 | 0.82 | MEN1 (0.41) | MEN1KMT2APTPN7ALDH1A1MAPT | |
| SCHEMBL29005892 | 0.82 | PPARD (0.45) | MEN1KMT2APTPN7ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7544736-B2 | Methods of preparing latex particulates with reactive functional groups | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2009-06-09 | — | — | US | claimed |
| US-7291514-B2 | Bottom electrode chemically-bonded Langmuir-Blodgett films via photolabile groups | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2007-11-06 | — | — | US | claimed |
| US-7175961-B2 | Photopatternable molecular circuitry | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2007-02-13 | — | — | US | claimed |
| US-7144683-B2 | Photopatternable molecular circuitry | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2006-12-05 | — | — | US | claimed |
| EP-1502929-B1 | Methods of preparing latex particulates with reactive functional groups | HEWLETT PACKARD DEVELOPMENT CO (US) | 2006-05-10 | — | — | EP | claimed |
| US-20060047060-A1 | Methods of preparing latex particulates with reactive functional groups | ZHOU ZHANG-LIN | 2006-03-02 | — | — | US | claimed |
| US-6995206-B2 | Methods of preparing latex particulates with reactive functional groups | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2006-02-07 | — | — | US | claimed |
| US-20050194526-A1 | Bottom electrode chemically-bonded Langmuir-Blodgett films via photolabile groups | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2005-09-08 | — | — | US | claimed |
| US-20050027065-A1 | Methods and preparing latex particulates with reactive functional groups | HEWLETT-PACKARD DEVELOPMENT COMPANY L.P. | 2005-02-03 | — | — | US | claimed |
| EP-1502929-A1 | Methods of preparing latex particulates with reactive functional groups | Hewlett-Packard Development Company, L.P. (US) | 2005-02-02 | — | — | EP | claimed |
| US-20040122233-A1 | Photopatternable molecular circuitry | BECK PATRICIA A (US) | 2004-06-24 | — | — | US | claimed |
| US-20030194630-A1 | Photopatternable molecular circuitry | HEWLETT-PACKARD DEVELOPMENT COMPANY L.P. | 2003-10-16 | — | — | US | claimed |
| US-20220411790-A1 | A CRISPR-CAS9 PLATFORM WITH AN INTRINSIC OFF-SWITCH AND ENHANCED SPECIFICITY | THE JOHNS HOPKINS UNIVERSITY | 2022-12-29 | — | — | US | disclosed |
| WO-2021081468-A1 | A CRISPR-CAS9 PLATFORM WITH AN INTRINSIC OFF-SWITCH AND ENHANCED SPECIFICITY | THE JOHNS HOKINS UNIVERSITY (US) | 2021-04-29 | — | — | WO | disclosed |
| EP-3587585-B1 | METHODS, KITS, AND SYSTEMS FOR MULTIPLEXED DETECTION OF TARGET MOLECULES AND USES THEREOF | MASSACHUSETTS GEN HOSPITAL (US) | 2021-03-24 | — | — | EP | disclosed |
| US-10655163-B2 | Methods, kits, and systems for multiplexed detection of target molecules and uses thereof | THE GENERAL HOSPITAL CORPORATION (US) | 2020-05-19 | — | — | US | disclosed |
| US-6410327-B2 | Methods for the selective regulation of DNA and RNA transcription and translation by photoactivation | VANDERBILT UNIVERSITY OFFICE OF TECHNOLOGY TRANSFER | 2002-06-25 | — | — | US | disclosed |
| US-20010024830-A1 | Methods for the selective regulation of DNA and RNA transcription and translation by photoactivation | VANDERBILT UNIVERSITY | 2001-09-27 | — | — | US | disclosed |
| US-6242258-B1 | Methods for the selective regulation of DNA and RNA transcription and translation by photoactivation | VANDERBILT UNIVERSITY | 2001-06-05 | — | — | US | disclosed |
| US-6017758-A | DMNPE caged nucleic acid and vector | VANDERBILT UNIVERSITY (US) | 2000-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040122233-A1 | Photopatternable molecular circuitry | CDH1, VIM, CAT | MEN1 2873/4885KMT2A 710/4885PTPN7 2967/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.